Antibodies

08 Aug 2007 Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Enter into Agreement to Humanize Two Monoclonal Antibodies for the Treatment of Alzheimer's Disease
04 Aug 2007 Bayer HealthCare and Regeneron initiate Phase 3 global development program for VEGF Trap-Eye in wet age-related macular degeneration (AMD)
03 Aug 2007 Genmab regains rights to HuMax-TAC
03 Aug 2007 Macrogenics Begins Global Phase 2/3 Protege Study In Recent-onset Type 1 Diabetes Mellitus
02 Aug 2007 ImmunoGen, Inc. Initiates Phase II Clinical Trial of HuC242-DM4
02 Aug 2007 Phase 2a Multi-dose Study Initiated By Medimmune In Patients With Asthma To Further Expand Anti-interleukin-9 Program
01 Aug 2007 ImmunoGen, Inc. Earns Milestone with Start of Trastuzumab-DM1 Phase II Testing
01 Aug 2007 Preliminary Data Add New Mechanistic Insights to Activity of Anthrax Anti-Toxin, Valortim(TM)
01 Aug 2007 YM BioSciences initiates patient enrolment in phase II colorectal cancer trial with EGFR antibody
01 Aug 2007 Joint FDA Advisory Committee Recommends Approval of TYSABRI(R) for the Treatment of Moderate to Severe Crohn's Disease
31 Jul 2007 BioWa Introduces its Second Technology to Dramatically Enhance Antibody Effector Function and the Launch of AccretaMab(TM) Platform
28 Jul 2007 US Food & Drug Administration approves Privigen(TM)
26 Jul 2007 Actemra monotherapy demonstrates significant clinical benefit in patients with rheumatoid arthritis
26 Jul 2007 Progenics Presents Additional Positive Clinical Results for HIV-Entry Inhibitor PRO 140 at International AIDS Meeting
24 Jul 2007 Amorfix acheives first milestone in herapeutic ALS partnership with Biogen Idec
24 Jul 2007 MedImmune Announces Interim Phase 1 Study Results for Potential Asthma Therapy
21 Jul 2007 Avastin receives positive opinion in Europe for first-line treatment of patients with advanced lung cancer
20 Jul 2007 Glenmark purchases rights to two therapeutic antibodies from Chromos
20 Jul 2007 Medarex Announces Advancement of Antibody Development by Partner
19 Jul 2007 Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
18 Jul 2007 Secondary endpoints of phase II/III study confirm clear benefits from treatment with removab(R) for patients with malignant ascites
17 Jul 2007 XOMA Initiates Phase I U.S. Trial in Type 2 Diabetes for XOMA 052, Monoclonal Antibody With Therapeutic Potential in Multiple Inflammatory Diseases
14 Jul 2007 CSL Behring Completes Enrollment for Phase III Registration Trial of Next Generation of Subcutaneous Immunoglobulin
13 Jul 2007 Amgen and Daiichi Sankyo announce agreement for denosumab in Japan
13 Jul 2007 Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top